技術指標
指標
數值
方向
MACD(12,26,9)
0.440
中性
RSI(14)
41.585
中性
STOCH(KDJ)(9,3,3)
36.456
中性
ATR(14)
1.401
低波動
CCI(14)
-73.900
中性
Williams %R
66.906
賣出
TRIX(12,20)
-0.323
賣出
StochRSI(14)
93.268
買入
搜尋
Boston Scientific Corp
BSX添加自選
43.590USD
+0.620+1.44%
收盤 07-23 16:00（美東）報價延遲15分鐘
64.79B總市值
18.13本益比TTM
關鍵數據
42.675今開
43.690最高
16.54M成交量
18.13本益比TTM
11.80本益比動
--股利TTM
1.11%換手率
42.970昨收
42.500最低
433.18M成交額
34.96本益比靜
2.50市淨率
0.00%股息率 TTM
8.42%ROA
109.50052週最高
0.99量比
1.85B淨利潤
1.49B總股本
2.4044每股盈餘TTM
0.58Beta
14.83%ROE
48.41052週最低
2.77%振幅
64.89%毛利率
64.79B總市值
-2.21回報/風險
1.52%風險率
TradingKey Boston Scientific Corp股票評分
單位: USD 更新時間: 2026-07-23操作建議
Boston Scientific Corp當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名12/200位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為75.01。中期看，股價處於下降通道。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Boston Scientific Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
45°C
過冷
過熱
看空
Boston Scientific Corp亮點
亮點風險
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
業績高增長
公司營業收入穩步增長，連續3年增長40.97%
利潤高增長
公司淨利潤處於行業前列，最新年度總收入20.07B美元
估值低估
公司最新PE估值18.13，處於3年歷史低位
機構減倉
最新機構持股1.40B股，環比減少1.09%
李安斯利持倉
明星投資者李安斯利持倉，最新持倉5.22M股
分析師目標
基於
33
分析師
買入
評級
75.008
目標均價
+73.67%
漲幅空間
Boston Scientific Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
33
分析師
買入
評級
75.008
目標均價
+73.67%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
88
總數
4
中位數
7
平均值
公司名稱
評級分佈
分析師數
Boston Scientific Corp
BSX
33
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
Danaher Corp
DHR
26
1
2
3
...
18
技術指標
移動平均線
指標
數值
方向
MA5
43.508
買入
MA10
43.725
賣出
MA20
43.987
賣出
MA50
47.642
賣出
MA100
56.117
賣出
MA200
74.684
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Boston Scientific Corp簡介
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
公司代碼BSX
公司Boston Scientific Corp
CEOMahoney (Michael F)
網址https://www.bostonscientific.com/en-US/Home.html
公司股東
相關品種
-1.77%
+8.73%
+0.22%
-1.08%
+7.39%
+3.22%
-2.54%
+0.18%
+1.33%
-2.54%
+0.46%
+1.48%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%熱門品種
51892.200
+168.200 (+0.33%)
28453.300
-124.700 (-0.44%)
7421.100
+1.200 (+0.02%)
14996.000
-105.000 (-0.69%)
64892.000
-479.000 (-0.73%)
6242.300
+26.600 (+0.43%)
89.573
-2.539 (-2.76%)
321.680
-4.210 (-1.29%)
208.770
-3.290 (-1.55%)
4054.340
+4.970 (+0.12%)
常見問題
Boston Scientific Corp(BSX)的當前股價是多少？
Boston Scientific Corp(BSX)的當前股價是 43.59。
Boston Scientific Corp 的股票代碼是什麼？
Boston Scientific Corp的股票代碼是BSX。
Boston Scientific Corp股票的52週最高點是多少？
Boston Scientific Corp股票的52週最高點是109.50。
Boston Scientific Corp股票的52週最低點是多少？
Boston Scientific Corp股票的52週最低點是48.41。
Boston Scientific Corp的市值是多少？
Boston Scientific Corp的市值是64.79B。
現在Boston Scientific Corp(BSX)的股票是買入、持有還是賣出？
根據分析師評級，Boston Scientific Corp(BSX)的總體評級為買入，目標價格為75.01。
Boston Scientific Corp(BSX)股票的每股收益（EPS TTM）是多少
Boston Scientific Corp(BSX)股票的每股收益（EPS TTM）是1.96。